International Journal of Clinical Case Reports, 2025, Vol.15, No.1, 34-43 http://medscipublisher.com/index.php/ijccr 40 investigated for its potential to promote tissue regeneration and repair, offering a novel approach to address the complex tissue damage associated with pelvic floor dysfunction (White and Rose, 2023). This therapy involves the use of stem cells to stimulate the growth of new, healthy tissue, potentially improving the structural and functional recovery of the pelvic floor (McConnell et al., 2020). 3D-printed implants represent another cutting-edge development, providing customized solutions that can be tailored to the unique anatomical and functional needs of each patient. These implants can be designed to fit precisely within the pelvic cavity, offering enhanced support and integration compared to traditional materials (Loverro et al., 2024). The use of 3D printing technology allows for the creation of complex structures that mimic the natural architecture of the pelvic floor, potentially improving the long-term success of reconstructive efforts. As these technologies continue to evolve, they offer exciting possibilities for improving the quality of life for patients undergoing pelvic floor reconstruction after gynecological malignancy surgery. 8 Challenges and Limitations in Current Diagnosis and Treatment 8.1 Barriers to early diagnosis and patient awareness Early diagnosis of Pelvic Floor Dysfunction (PFD) in patients with gynecological malignancies is often hindered by a lack of awareness among both patients and healthcare providers. Many women with gynecological cancers experience PFDs, such as urinary and fecal incontinence, as well as sexual dysfunction, but these symptoms are frequently overlooked or underreported (Bodean et al., 2018). This oversight is partly due to the primary focus on cancer eradication, which can overshadow the importance of addressing quality of life issues related to PFDs. Additionally, there is a lack of systematic screening for PFDs in the gynecologic oncology population, which further contributes to delayed diagnosis and management (Hall et al., 2018). Patient awareness is another significant barrier. Many women are not informed about the potential for PFDs following cancer treatment, which can lead to underreporting of symptoms and a lack of proactive management (Marcu et al., 2023). This gap in communication can result in patients not seeking help until symptoms become severe, thereby complicating treatment and reducing the effectiveness of interventions aimed at improving quality of life. 8.2 Risks and complications associated with treatment options The treatment of gynecological malignancies often involves radical surgeries, radiation, and chemotherapy, all of which can significantly impact pelvic floor function. These treatments can lead to complications such as stress and urge urinary incontinence, voiding difficulties, and pelvic organ prolapse (Vilos et al., 2020). For instance, radical surgeries like pelvic exenteration, although sometimes necessary, are associated with high morbidity and can severely disrupt pelvic anatomy, necessitating complex reconstructive procedures (Loverro et al., 2024). Moreover, the use of radiation therapy, while effective in treating cancer, can exacerbate PFDs by causing damage to surrounding tissues, leading to symptoms such as urinary incontinence and pelvic organ prolapse (Opławski et al., 2021). The complexity of these treatments requires careful consideration of the potential risks and benefits, as well as the need for comprehensive preoperative counseling to manage patient expectations and prepare them for possible outcomes. 8.3 Need for individualized care based on patient-specific factors Given the diverse presentations and impacts of PFDs in gynecological cancer survivors, there is a critical need for individualized care plans that consider patient-specific factors such as age, body mass index, and comorbidities. These factors can influence the severity of PFDs and the effectiveness of treatment options, necessitating a personalized approach to care (Lakomy et al., 2022). For example, older age and higher body mass index have been associated with worse urinary-related symptoms, highlighting the need for tailored interventions. Individualized care also involves integrating multidisciplinary teams to address the complex needs of these patients. High-volume centers with expertise in both oncology and pelvic floor disorders can offer more comprehensive care, potentially improving outcomes and reducing morbidity. Additionally, incorporating patient
RkJQdWJsaXNoZXIy MjQ4ODYzNA==